The Robot That Moves Between Operating Rooms

CMR Surgical's Versius Plus enters the US market with a flexible, room-to-room design and 45,000 procedures of global proof

6 May 2026

Robotic surgery in America has long had one dominant name. CMR Surgical is betting that's about to change. The UK-based company launched Versius Plus commercially in the US this spring, introducing a modular surgical robot designed to go where traditional systems can't, or won't.

The FDA cleared Versius Plus in December 2025 for cholecystectomy, and its formal US debut came at the SAGES conference in Tampa on March 26. Globally, the robot has already logged more than 45,000 procedures across 30-plus countries, making it the second most widely used surgical robot in the world outside the United States.

What distinguishes Versius Plus isn't just its track record. Unlike conventional fixed-room systems, it uses independent modular arms that can move between operating rooms within the same facility. No dedicated OR required. For health systems watching capital budgets and juggling unpredictable caseloads, that kind of flexibility can meaningfully change the economics of robotic adoption.

"Versius Plus was designed to meet the practical realities of today's healthcare environment," said Chris O'Hara, CMR Surgical's US President and General Manager. The company is targeting both hospitals and ambulatory surgery centers as it accelerates its rollout.

The timing is well-chosen. The US surgical robotics market was valued at $4.58 billion in 2025 and is projected to hit $15.46 billion by 2035. Demand for minimally invasive procedures is rising, and OR efficiency pressure isn't letting up. CMR is already looking beyond its initial clearance: on April 29, it filed a new 510(k) application to expand into benign gynecologic indications.

Tens of thousands of real-world cases across multiple specialties give US surgeons something concrete to evaluate. In a market where incumbents have years of installed infrastructure, that clinical footprint matters more than a polished sales pitch. CMR Surgical isn't just entering the US market. It's making a credible argument for why hospitals should rethink how they buy into robotics altogether.